Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,389.3
-63.7 (-2.60%)

 

  • STI Straits Times Index
    2,389.3
    -63.7 (-2.60%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,330.7
    -0.2 (-0.02%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,236.1
    -44.0 (-0.19%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,764.0
    -16.7 (-0.60%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    17,820.2
    1.5 (0.01%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,623.4
    91.7 (2.02%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,324.3M
  • Value: 1,512.2M
  • Rise: 65
  • Fall: 270
  • Unch: 476

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.095-0.001
ESR-REIT0.250-0.015
Genting Sing0.650-0.015
Mapletree Com Tr1.500-0.120
CapitaMall Trust1.520-0.100
Interra Resource^0.042+0.001
Singtel2.580-0.040
Medtecs Intl0.095+0.005
AusGroup^0.021-0.003
JCG Investment0.002-

World Indices

World Indices
Name Last Change
Nasdaq 7,373.1 -114.2
HSI 23,236.1 -44.0
HSCEI 9,491.1 -35.5
Jakarta 4,623.4 +91.7
Nikkei 225 17,820.2 +1.5
SSE Comp 2,764.0 -16.6
Shanghai A 2,896.6 -17.5
Shanghai B 216.0 -0.8
KOSPI 1,725.4 +0.6

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

3SBIO 3SBIO
Quotes 15 Minutes Delayed. Updated at 03 Apr 2020 16:08
Last (HKD): 8.050 Change: -0.140 High: 8.180 Remarks: -
Change (%): -1.71 Low: 7.850
Open 8.050 Yesterday's Close 8.190
Buy Price 8.040 Sell Price 8.040
Buy Volume ('000) 446 Sell Volume ('000) 228
Cumulative Volume ('000) 6,278.981 Cumulative Value 50,557,179
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.59558 Trailing EPS (HKD) e 0.43219 NAV (HKD) b 4.2388
PE a 13.516 Trailing PE f 18.626 Price / NAV b 1.8991
Dividend (HKD) d - Cash In Hand (HKD) g 0.9270 Issued & Paid-up Shares c 2,539,970,000
Dividend Yield (%) d - Price / Cash In Hand g 8.684 Treasury Shares h -
Beta - 75 Daysi 1.168 R-Squared - 75 Days(%)i 23.87 Market Cap (M) 20,446.758
Beta - 500 Daysi 1.177 R-Squared - 500 Days (%)i 21.27 Enterprise Value (M) 21,530.251
Piotroski F Score 5 Exchange Code 1530 Par Value ( USD ) n.a.
52 Weeks Volatility (%) 46.83 6-Month VWAP 10.166 Free Float (%) 48.8
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 07 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 01 Oct 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference 3SBIO HKEx 20,446.758 13.516 18.626 1.8991 -
Industry Biotechnology HKEx 49,675.750 14.016 18.044 6.3348 2.609
Local Peer AMGEN-T HKEx 589,807.000 8.965 9.598 7.8255 4.417
Local Peer WUXI BIO HKEx 145,043.916 194.191 126.359 10.1425 -
Local Peer SINO BIOPHARM HKEx 132,595.044 12.375 43.078 3.8100 0.694
Local Peer BEIGENE HKEx 80,435.200 - - 10.7286 -
Local Peer GENSCRIPT BIO HKEx 22,292.636 134.071 - 7.4741 -
Local Peer ALPHAMAB-B HKEx 13,082.736 - - -36.7125 -
Local Peer HAOHAI BIOTEC HKEx 8,153.425 16.606 18.404 1.9197 1.275
Local Peer FRONTAGE HKEx 6,514.006 73.930 45.104 3.1595 -
Local Peer VIVA BIOTECH HKEx 6,388.376 59.560 21.438 3.2131 -
Local Peer ASCENTAGE-B HKEx 4,359.652 - - 4.3768 -
Local Peer ASCLETIS-B HKEx 3,075.625 - - 0.8271 -
Local Peer SINOMAB BIO-B HKEx 2,897.971 - - - -
Other Local Peers ESSEX BIO-TECH (HKEx), LEE'S PHARM (HKEx), BBI LIFE SCI (HKEx), UNI-BIO GROUP (HKEx), CT ENTERPRISE (HKEx), BIOSINO BIO-TEC (HKEx), REGENT PACIFIC (HKEx), HAO WEN HLDGS (HKEx)
Global Peer AMGEN INC NASDAQ 121,152.256 14.433 15.449 12.5248 2.744
Global Peer GILEAD SCIENCES INC NASDAQ 98,467.172 18.051 18.282 4.3715 2.968
Global Peer CSL ASX 138,080.841 51.467 47.667 15.9660 0.872
Global Peer VERTEX PHARMACEUTICAL NASDAQ 61,786.395 29.473 52.503 10.1535 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 54,275.052 22.204 25.652 4.8942 -
Global Peer BIOGEN INC NASDAQ 52,307.973 11.806 8.883 3.9202 -
Global Peer ILLUMINA INC NASDAQ 38,734.500 46.894 38.657 8.3968 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 21,805.623 69.005 28.541 4.4979 0.869
Global Peer SEATTLE GENETICS INC NASDAQ 20,070.013 - - 10.6966 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 19,937.917 256.934 8.293 1.7688 -
Other Global Peers INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), MODERNA INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), Lonza (SGX), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), FIBROGEN INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), KODIAK SCIENCES INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ALECTOR INC (NASDAQ), XENCOR INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), VIELA BIO INC (NASDAQ), ARVINAS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), EPIZYME INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), CORTEXYME INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), NEXTCURE INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), NOVAVAX INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), CYTOKINETICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), ARCUS BIOSCIENCES INC (NYSE), OMEROS CORP (NASDAQ), PASSAGE BIO INC (NASDAQ), RETROPHIN INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), KADMON HLDGS INC (NYSE), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), TRANSLATE BIO INC (NASDAQ), COMPUGEN (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), AVITA MEDICAL LTD (ASX), VANDA PHARMACE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), ARDELYX INC (NASDAQ), AVROBIO INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), PRECIGEN INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), MESOBLAST LTD (ASX), RAPT THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), VERASTEM INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ANAPTYSBIO INC (NASDAQ), AGENUS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), XBIOTECH INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), NANOVIRICIDES INC (NYSE American), VIKING THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), MACROGENICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), KAMADA (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), PERSONALIS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), DPHARMA (Bursa), SERES THERAPEUTICS (NASDAQ), GERON CORP (NASDAQ), ADURO BIOTECH INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), PFENEX INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), LEXICON PHARMACEUTICALS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), VBI VACCINES INC CDA (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), RECRO PHARMA INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CABALETTA BIO INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), IVERIC BIO INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), INFLARX N V (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), CHIASMA INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), AFFIMED N V (NASDAQ), VAXART INC (NASDAQ), NEXT SCIENCE LTD (ASX), ENZO BIOCHEM INC (NYSE), PIERIS PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), FENNEC PHARMACEUTICALS INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), SAVARA INC (NASDAQ), CEL-SCI CORP (NYSE American), IBIO INC (NYSE American), IMV INC (NASDAQ), CHIMERIX INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ARAVIVE INC (NASDAQ), CONTRAFECT CORP (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VERMILLION INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), ORGENESIS INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), CATABASIS PHARMACEUTICALS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), ARBUTUS BIOPHARMA CORP (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), OTONOMY INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), SYNLOGIC INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), IMUGENE LIMITED (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), NABRIVA THERAPEUTICS PLC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), BIOTRON (ASX), TREVENA INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), SOLIGENIX INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), RESTORBIO INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), INMUNE BIO INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ADVAXIS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), ZAFGEN INC (NASDAQ), IMMUTEP LTD (ASX), ATYR PHARMA INC (NASDAQ), ORAGENICS INC (NYSE American), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CURIS INC (NASDAQ), EVOGENE LTD (NASDAQ), TOCAGEN INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), KAZIA THERAPEUTICS LIMITED (ASX), SEELOS THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), MEMPHASYS LTD (ASX), CLEVELAND BIOLABS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ANTEOTECH LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), DIFFUSION PHARMACEUTICALS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), OCUGEN INC (NASDAQ), Suntar Eco-City^ (SGX), GENETIC TECHNOLOGIES (ASX), BIONOMICS LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), CCP TECHNOLOGIES LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), REGENEUS LTD (ASX), AETERNA ZENTARIS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PATRYS LIMITED (ASX), CAPRICOR THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), TRACON PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), RHINOMED LIMITED (ASX), REXAHN PHARMACEUTICALS INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), PRECIPIO INC (NASDAQ), SIENNA CANCER DIAGNOSTICS LTD (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), LEAF RESOURCES LTD (ASX), BENITEC BIOPHARMA LTD (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ADALTA LTD (ASX), SENESTECH INC (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CRYOSITE (ASX), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), FACTOR THERAPEUTICS LIMITED (ASX), NANOLLOSE LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.320
-3.82 %
10 Days -+0.900
+12.59 %
20 Days --0.760
-8.63 %
Medium Term Return 3 Months --2.050
-20.30 %
6 Months --5.470
-40.46 %
1 Year --7.430
-48.00 %
Long Term Return 2 Years 0.069-10.950
-57.27 %
3 Years 0.069-1.570
-15.60 %
Annualised Return Annualised --
-5.50 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 6.660 - 16.420 Change From 1 Year Low +1.390 % Change From 1 Year Low (%) +20.87
Change From 1 Year High -8.370 % Change From 1 Year High (%) -50.97
2 Years Range 6.660 - 23.250 Change From 2 Years Low +1.390 % Change From 2 Years Low (%) +20.87
Change From 2 Years High -15.200 % Change From 2 Years High (%) -65.38
5 Years Range 6.660 - 23.250 Change From 5 Years Low +1.390 % Change From 5 Years Low (%) +20.87
Change From 5 Years High -15.200 % Change From 5 Years High (%) -65.38
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products. It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation, and infectious diseases. The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.

Historical Price Data

Date Open High Low Close Volume VWAP
03 Apr 2020 8.050 8.180 7.850 8.050 6,278,981 8.0518
02 Apr 2020 8.010 8.210 7.750 8.190 8,640,591 8.0517
01 Apr 2020 8.080 8.390 8.000 8.070 20,315,738 8.1392
31 Mar 2020 8.230 8.500 8.010 8.070 16,139,583 8.1341
30 Mar 2020 8.470 8.780 8.100 8.230 13,956,975 8.4018
27 Mar 2020 8.900 9.000 8.270 8.370 22,216,828 8.4798
26 Mar 2020 8.780 9.480 8.550 8.700 53,240,730 8.9007
25 Mar 2020 7.050 8.430 7.050 8.280 30,083,453 7.9676
24 Mar 2020 6.810 7.100 6.800 6.850 8,492,365 6.9241
23 Mar 2020 6.900 7.040 6.780 6.810 9,737,782 6.9204
20 Mar 2020 7.280 7.280 6.900 7.150 21,470,820 7.1035
19 Mar 2020 7.360 7.550 6.660 6.940 19,232,898 6.8444
18 Mar 2020 7.370 7.540 6.810 7.010 16,883,028 7.1895
17 Mar 2020 7.060 7.410 7.030 7.330 14,440,808 7.2286
16 Mar 2020 7.620 7.820 7.180 7.250 11,113,073 7.4058
13 Mar 2020 7.500 7.940 7.300 7.800 16,158,463 7.6252
12 Mar 2020 8.300 8.360 7.940 7.970 23,625,322 8.0749
11 Mar 2020 8.430 8.750 8.340 8.360 8,354,676 8.4102
10 Mar 2020 8.430 8.550 8.240 8.320 19,025,855 8.3469
09 Mar 2020 8.470 8.660 8.220 8.490 13,969,981 8.4944
06 Mar 2020 9.000 9.020 8.720 8.810 11,196,986 8.9530
05 Mar 2020 8.600 8.770 8.570 8.740 19,951,493 8.7309
Summary
Current 2 Weeks
(23 Mar 2020 to 03 Apr 2020)
6.900 9.480 6.780 8.050 189,103,026 -
Previous 2 Weeks
(09 Mar 2020 to 20 Mar 2020)
8.470 9.480 6.780 7.150 164,274,924 -
4 Weeks from
(10 Feb 2020 to 06 Mar 2020)
10.580 10.960 6.780 8.810 304,036,212 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.